VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EBMT 2021 | T-Cell lymphoma: implications of interleukin-10 loss

Ali Bazarbachi, MD, PhD, American University of Beirut Medical Center, Beirut, Lebanon, discusses the challenges of treating adult T-cell leukemia/lymphoma (TCL). Prof. Bazarbachi outlines the results of a study that demonstrated that arsenic trioxide (AS) and interferon-α (IFNα)-induced abrogation of leukemia-initiating cell activity requires IL-10 expression shutoff in patients with adult TCL. This loss of IL-10 results in increased production of inflammatory cytokines, resulting in innate immunity-mediated clearance of Tax-driven leukemic cells. This interview took place during the 47th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT) 2021.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter